Ipamorelin Research
Selective Growth Hormone Secretagogue
growth hormone signaling
Immune Support, Training and Energy
Educational information only. Investigational uses may lack FDA approval. Not medical advice or a treatment plan.
Ipamorelin is a third-generation synthetic pentapeptide growth hormone secretagogue (GHS) studied for its selective activity at the growth hormone secretagogue receptor (GHSR). Unlike earlier GHS compounds, it is noted in research for its selectivity — stimulating growth hormone release with minimal reported effect on cortisol or prolactin signaling pathways, making it a subject of interest in GH axis research.
Research areas
GHSR Signaling & Selectivity Research
Research focuses on Ipamorelin's selective binding at GHSR-1a receptors and its downstream signaling cascade, investigating why it produces growth hormone pulses with less activation of cortisol and prolactin pathways compared to earlier secretagogues.
Pulsatile Growth Hormone Release Research
Studies examine its ability to stimulate discrete, physiological-style GH secretion pulses from pituitary somatotrophs, exploring its effects on GH pulse amplitude and frequency signaling research.
IGF-1 Axis Pathway Research
Researchers investigate downstream effects on hepatic IGF-1 production signaling, IGF-1 receptor activation pathways, and tissue-level anabolic signaling research associated with GH secretion.
Body Composition & Metabolic Signaling
Studies explore its effects on fat metabolism signaling, lean tissue preservation pathways, and metabolic rate research associated with growth hormone axis modulation.
Investigational compound. Not FDA-approved. Often studied in combination with CJC-1295. Not medical advice.
Have questions about Ipamorelin?
Request a free consultation to ask questions and learn more about this research area.
Request a free consultation